✦ LIBER ✦

Production of functional dendritic cells from menstrual blood—a new dendritic cell source for immune therapy

✍ Scribed by Pham Van Phuc; Dang Hoang Lam; Vu Bich Ngoc; Duong Thi Thu; Nguyen Thi Minh Nguyet; Phan Kim Ngoc

Book ID: 107427347
Publisher: Society for In Vitro Biology
Year: 2011
Tongue: English
Weight: 544 KB
Volume: 47
Category: Article
ISSN: 1475-2689
DOI: 10.1007/s11626-011-9399-2

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Pluripotent stem cells as source of dend

Pluripotent stem cells as source of dendritic cells for immune therapy

✍ Satoru Senju; Shinya Hirata; Yutaka Motomura; Daiki Fukuma; Yusuke Matsunaga; Sa 📂 Article 📅 2010 🏛 Carden Jennings Publishing 🌐 English ⚖ 324 KB

Impairment of dendritic cell function by

Impairment of dendritic cell function by excretory-secretory products: A potential mechanism for nematode-induced immunosuppression

✍ Mariela Segura; Zhong Su; Ciriaco Piccirillo; Mary M. Stevenson 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 689 KB

## Abstract To determine whether helminth‐derived products modulate dendritic cell (DC) function, we investigated the effects of excretory‐secretory products (ES) and adult worm homogenate (AWH) derived from the gastrointestinal nematode __Heligmosomoides polygyrus__ (Hp) on murine bone marrow‐deri

Closed system generation of dendritic ce

Closed system generation of dendritic cells from a single blood volume for clinical application in immunotherapy

✍ M. Elias; J. van Zanten; G.A.P. Hospers; A. Setroikromo; M.A. de Jong; L.F.M.H. 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 440 KB

Dendritic cells (DC) used for clinical trials should be processed on a large scale conforming to current good manufacturing practice (cGMP) guidelines. The aim of this study was to develop a protocol for clinical grade generation of immature DC in a closed-system. Aphereses were performed with the C

Report of immune monitoring of prostate

Report of immune monitoring of prostate cancer patients undergoing T-cell therapy using dendritic cells pulsed with HLA-A2-specific peptides from prostate-specific membrane antigen (PSMA)

✍ Salgaller, Michael L.; Lodge, Patricia A.; McLean, Joanne G.; Tjoa, Ben A.; Loft 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 336 KB 👁 2 views

## BACKGROUND. In this paper we describe our program for the immune monitoring of phase II participants given dendritic cell (DC)/prostate-specific membrane antigen (PSMA)-based immunotherapy, and we also present some initial findings. METHODS. Phase II subjects received six administrations of aut